Tau-PET-based biological staging of Alzheimer’s disease in vivo

被引：0
|
作者：
机构：
来源：
Nature Aging | 2022年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
High-affinity tau-PET was used to apply the Braak neuropathological staging system for Alzheimer’s disease in vivo. Tau-PET can be used to stage Alzheimer’s disease from presymptomatic to clinical dementia phases in people, while also providing a framework to model the natural history of Alzheimer’s disease using biomarkers.
引用
收藏
页码：471 / 472
页数：1
相关论文
共 50 条
  • [11] Novel PET probes for in vivo imaging of tau pathology in Alzheimer's disease
    Ito, S
    Okamura, N
    Katou, M
    Furumoto, S
    Akatsu, H
    Yamamoto, T
    Sawada, T
    Arai, H
    Kudo, Y
    Yanai, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 143P - 143P
  • [12] Biological staging of Alzheimer's disease
    Rosa-Neto, Pedro
    Therriault, Joseph
    Macedo, Arthur Cassa
    Pascoal, Tharick A.
    Stevenson, Jenna
    Rahmouni, Nesrine
    Vitali, Paolo
    Tissot, Cecile
    Servaes, Stijn
    Gauthier, Serge
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [13] Tau PET Imaging in Alzheimer's Disease
    Okamura, Nobuyuki
    Harada, Ryuichi
    Furumoto, Shozo
    Arai, Hiroyuki
    Yanai, Kazuhiko
    Kudo, Yukitsuka
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2014, 14 (11)
  • [14] Tau PET Imaging in Alzheimer’s Disease
    Nobuyuki Okamura
    Ryuichi Harada
    Shozo Furumoto
    Hiroyuki Arai
    Kazuhiko Yanai
    Yukitsuka Kudo
    Current Neurology and Neuroscience Reports, 2014, 14
  • [15] In vivo tau imaging in Alzheimer's disease
    Villemagne, Victor
    Furumoto, Shozo
    Fodero-Tavoletti, Michelle
    Mulligan, Rachel
    Hodges, John
    Kudo, Yukitsuka
    Masters, Colin
    Yanai, Kazuhiko
    Rowe, Christopher
    Okamura, Nobuyuki
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [16] IN VIVO TAU IMAGING IN ALZHEIMER'S DISEASE
    Villemagne, Victor L.
    Furumoto, Shozo
    Fodero-Tavoletti, Michelle T.
    Mulligan, Rachel S.
    Harada, Ryuichi
    Yanai, Kazuhiko
    Masters, Colin L.
    Kudo, Yukitsuka
    Rowe, Christopher C.
    Okamura, Nobuyuki
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 4 - 4
  • [17] Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging
    Charil, Arnaud
    Shcherbinin, Sergey
    Southekal, Sudeepti
    Devous, Michael D.
    Mintun, Mark
    Murray, Melissa E.
    Miller, Bradley B.
    Schwarz, Adam J.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (03) : 1037 - 1048
  • [18] In vivo Braak staging of tau pathology in Alzheimer's disease: A multicenter [18F]PI-2620 PET study
    Rullmann, M.
    Brendel, M.
    Schroeter, M. L.
    Saur, D.
    Levin, J.
    Perneczky, R.
    Tiepolt, S.
    Patt, M.
    Mueller, A.
    Villemagne, V.
    Classen, J.
    Stephens, A. W.
    Sabri, O.
    Barthel, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S172 - S173
  • [19] The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
    Macedo, Arthur C.
    Therriault, Joseph
    Servaes, Stijn
    Wang, Yi-Ting
    Fernandez-Arias, Jaime
    Rahmouni, Nesrine
    Lussier, Firoza Z.
    Vermeiren, Marie
    Bezgin, Gleb
    Vitali, Paolo
    Ng, Kok Pin
    Zimmer, Eduardo R.
    Guiot, Marie-Christine
    Pascoal, Tharick A.
    Gauthier, Serge
    Rosa-Neto, Pedro
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (08) : 1171 - 1178
  • [20] Tau-PET abnormality as a biomarker for Alzheimer's disease staging and early detection: a topological perspective
    Ding, Jie
    Shen, Chushu
    Wang, Zhenguo
    Yang, Yongfeng
    El Fakhri, Georges
    Lu, Jie
    Liang, Dong
    Zheng, Hairong
    Zhou, Yun
    Sun, Tao
    CEREBRAL CORTEX, 2023, : 10649 - 10659
12345